POSTERS & PUBLICATIONS

An image of a male scientist sitting at a bench in a lab. He is wearing a white lab coat, clear goggles and blue gloves. There are a series of red test tubes set up in front of him. He is holding a spare red test tube in his left hand and is squeezing fluid from a scientific device into the remaining test tubes with his right hand.

Posters & publications

TITLE
DOWNLOAD
Foundation Fighting Blindness 2025 Presentation: Advancing PRPF31 Related Retinitis Pigmentosa Treatment: Key Insights from the VP-001 Phase 1B Study
RANZCO 2024 presentation: a Phase 1 first-in-human study of VP-001 designed to treat retinitis pigmentosa type 11
ARVO 2024 presentation: a peptide conjugated oligonucleotide for the treatment of retinitis pigmentosa type 11
VP-001 as an interventional therapy for patients with PRPF31 mutation-associated retinal dystrophy
RNA therapeutics in the treatment of retinal disease: delivering the potential
Enhancement of antisense oligomer cell penetration in retinal layers using a modular cell penetrating peptide platform
Modulation of CNOT3 expression using antisense oligomers to treat retinitis pigmentosa type 11
GFP-complementation assay to detect functional CPP and protein delivery into living cells
Exploring microperimetry and autofluorescence endpoints for monitoring disease progression in PRPF31-associated retinopathy
PYC-001, a peptide-conjugated phosophorodiamidate morpholino oligomer for the treatment of autosomal dominant optic atrophy